EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss

Jutta S Swolinsky iD, Ricarda M Hinz iD, Carolin E Markus, Eugenia Singer, Friederike Bachmann iD, Fabian Halleck, Susanne Kron iD, Marcel G Naik iD, Danilo Schmidt iD, Martin Obermeier iD, Pimrapat Gebert iD, Geraldine Rauch iD und 6 weitere

Nephrology Dialysis Transplantation · 2024

DOI: 10.1093/ndt/gfad226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Jutta S Swolinsky und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-…. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to investigate the utility of neutrophil gelatinase-associated lipocalin (NGAL) and calprotectin (CPT) to predict long-term graft survival in stable kidney transplant recipients (KTR).

Methods

A total of 709 stable outpatient KTR were enrolled >2 months post-transplant. The utility of plasma and urinary NGAL (pNGAL, uNGAL) and plasma and urinary CPT at enrollment to predict death-censored graft loss was evaluated during a 58-month follow-up.

Results

Among biomarkers, pNGAL showed the best predictive ability for graft loss and was the only biomarker with an area under the curve (AUC) > 0.7 for graft loss within 5 years. Patients with graft loss within 5 years (n = 49) had a median pNGAL of 304 [interquartile range (IQR) 235–358] versus 182 (IQR 128–246) ng/mL with surviving grafts (P < .001). Time-dependent receiver operating characteristic analyses at 58 months indicated an AUC for pNGAL of 0.795, serum creatinine–based Chronic Kidney Disease Epidemiology Collaboration estimated glomerular filtration rate (eGFR) had an AUC of 0.866. pNGAL added to a model based on conventional risk factors for graft loss with death as competing risk (age, transplant age, presence of donor-specific antibodies, presence of proteinuria, history of delayed graft function) had a strong independent association with graft loss {subdistribution hazard ratio (sHR) for binary log-transformed pNGAL [log2(pNGAL)] 3.4, 95% confidence interval (CI) 2.24–5.15, P < .0001}. This association was substantially attenuated when eGFR was added to the model [sHR for log2(pNGAL) 1.63, 95% CI 0.92–2.88, P = .095]. Category-free net reclassification improvement of a risk model including log2(pNGAL) in addition to conventional risk factors and eGFR was 54.3% (95% CI 9.2%–99.3%) but C-statistic did not improve significantly. Conclusions pNGAL was an independent predictor of renal allograft loss in stable KTR from one transplant center but did not show consistent added value when compared with baseline predictors including the conventional marker eGFR. Future studies in larger cohorts are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansAcute-Phase ProteinsAllograftsBiomarkersLipocalin-2LipocalinsProto-Oncogene Proteins

Stichwörter der Autor:innen

NGALbiomarkerscalprotectingraft survivalkidney transplantation

Substanzen

Acute-Phase ProteinsBiomarkersLipocalin-2LipocalinsProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Nephrology and Medical Intensive…
  • Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin.
  • Medizinisches Infektiologiezentrum (MIB), Berlin, Germany.
  • Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology.
  • Institute of Biometry and Medical Informatics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

ORCID-Profile: Jutta S Swolinsky, Ricarda M Hinz, Friederike Bachmann, Susanne Kron, Marcel G Naik, Danilo Schmidt, Martin Obermeier, Pimrapat Gebert, Geraldine Rauch, Siegfried Kropf, Michael Haase, Klemens Budde, Kai-Uwe Eckardt, Timm H Westhoff, Kai M Schmidt-Ott

Zitieren

APA

Swolinsky, J. S., Hinz, R. M., Markus, C. E., Singer, E., Bachmann, F., Halleck, F., Kron, S., Naik, M. G., Schmidt, D., Obermeier, M., Gebert, P., Rauch, G., Kropf, S., Haase, M., Budde, K., Eckardt, K. U., Westhoff, T. H., & Schmidt-Ott, K. M. (2024). Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad226

Vancouver

Swolinsky JS, Hinz RM, Markus CE, Singer E, Bachmann F, Halleck F, et al. Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfad226

BibTeX
@article{Swolinsky2024,
  author = {Swolinsky, Jutta S and Hinz, Ricarda M and Markus, Carolin E and Singer, Eugenia and Bachmann, Friederike and Halleck, Fabian and Kron, Susanne and Naik, Marcel G and Schmidt, Danilo and Obermeier, Martin and Gebert, Pimrapat and Rauch, Geraldine and Kropf, Siegfried and Haase, Michael and Budde, Klemens and Eckardt, Kai-Uwe and Westhoff, Timm H and Schmidt-Ott, Kai M},
  title = {Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfad226}
}
Kostenlos starten →